How Elite Peps Australia Evaluates Scientific Evidence

Elite Peps Australia is an independent scientific knowledge base. Our job is to make complex peptide and metabolic-research evidence easier to navigate without turning preliminary findings into medical claims. This page explains how we select, classify, review and update information.

Our evidence hierarchy

Not every source answers the same question. We give the greatest weight to evidence that is transparent, reproducible and appropriate to the claim being made.

1. Regulatory and official records: current documents from Australian regulators and other recognised authorities, medicine labels, safety communications and public assessment reports.
2. Registered clinical trials: trial registries are used to verify study design, status, enrolment, outcomes and dates. A registry entry is not proof that a treatment works.
3. Peer-reviewed human research: randomised trials, controlled studies and carefully interpreted observational research.
4. Systematic reviews and meta-analyses: useful for synthesising a body of evidence, provided the included studies and methods are suitable.
5. Preclinical research: animal, cell and biochemical studies that can explain mechanisms or generate hypotheses, but cannot establish human benefit or safety.
6. Expert commentary and secondary reporting: used for context, never as a substitute for primary evidence.

We label the stage of evidence

Every substantive article should make clear whether a finding comes from in vitro work, animal research, early human investigation, a controlled clinical trial, post-market evidence or regulatory review. We do not collapse these categories into a single claim. A molecular pathway observed in a laboratory is a starting point for investigation, not a clinical conclusion.

How we read a study

Our reviews consider the research question, study design, comparator, sample size, participant population, duration, endpoints, statistical uncertainty, missing data, funding and conflicts of interest. We distinguish surrogate endpoints from outcomes that directly matter to people. We also look for replication and whether the result is consistent with the wider evidence base.

Absolute effects matter

Relative percentages can sound dramatic while hiding a small absolute difference. Where the source permits, we report absolute numbers, denominators, confidence intervals and the time period studied. We avoid extrapolating beyond the tested population, dose, formulation or duration.

Publication is not the same as proof

Peer review is an important filter, but it does not eliminate bias, error or irreproducibility. Preprints are labelled as not yet peer reviewed. Conference abstracts are treated as preliminary because methods and results may be incomplete.

Trials, dates and changing knowledge

Trial status can change. We date-stamp material that depends on a live registry or regulatory position and link to the underlying record wherever possible. We distinguish the date an event occurred from the date it was reported. Readers should verify live trial status in the linked registry before relying on a summary.

Our Clinical Trials hub explains development phases and tracks important studies. Australian legal and regulatory context belongs in Australia & Regulation. Laboratory methods and quality concepts are organised under Laboratory Science.

Sources and citations

We prefer direct links to journal papers, trial registries, official labels, regulator publications and recognised standards. Citations should support the sentence or section beside them. When full text is unavailable, we state the limitation rather than infer details from an abstract.

• PubMed for biomedical literature
• ClinicalTrials.gov and other recognised trial registries
• Therapeutic Goods Administration for current Australian regulatory information
• Australian New Zealand Clinical Trials Registry

Corrections, updates and conflicts

Material claims should be reviewed when important evidence, trial results or regulation changes. Substantive corrections are recorded rather than silently rewritten. Readers can see our Editorial Policy and Corrections Policy for the standards applied across the site.

Advertising must remain separate from editorial judgement. Our Advertising Policy describes that boundary. Advertising placement never determines whether a compound, study or regulator is covered, and commercial copy is not presented as scientific evidence.

What this site does not do

Elite Peps Australia does not sell peptides and does not provide personalised medical advice, diagnosis, prescribing, dosing, administration or treatment recommendations. Scientific summaries cannot account for an individual’s health history. Health decisions should be discussed with a suitably qualified Australian healthcare professional.

How to challenge or improve an article

Good evidence work is corrigible. If you identify a factual error, outdated trial status, broken citation or important omitted source, use our Contact page and include the article URL plus the supporting primary source. We review specific, verifiable corrections as a priority.